Advertisement

Review of Major Registries and Clinical Trials of Late Outcomes After Transcatheter Aortic Valve Replacement

      The results of the Placement of AoRtic TraNscathetER Valves (PARTNER) 2 trial established the feasibility of transcatheter aortic valve replacement (TAVR) for intermediate surgical risk patients. The expansion of TAVR into the low-risk patient population will largely depend on its durability outcomes due to the high life expectancy in low-risk patients. Long-term follow-up results from low-risk clinical trials will take several years to be reported. Given this, we performed a systematic review of current long-term data to provide further insights into TAVR durability and long-term patient survival. We searched MEDLINE, Embase, Google Scholar, BIOSIS, and major conference abstracts for TAVR studies with follow-up of at least 4 years. Abstracts were retrieved and independently reviewed for eligibility. Final studies were selected irrespective of the type of TAVR valve, route of vascular access, or surgical risk profile. A total of 12 studies met the inclusion criteria. We reviewed data from these studies with emphasis on long-term survival and echocardiographic findings.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Thyregod H.G.
        • Steinbruchel D.A.
        • Ihlemann N.
        • Nissen H.
        • Kjeldsen B.J.
        • Petursson P.
        • Chang Y.
        • Franzen O.W.
        • Engstrom T.
        • Clemmensen P.
        • Hansen P.B.
        • Andersen L.W.
        • Olsen P.S.
        • Sondergaard L.
        Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial.
        J Am Coll Cardiol. 2015; 65: 2184-2194
        • Arora S.
        • Strassle P.D.
        • Ramm C.J.
        • Rhodes J.A.
        • Vaidya S.R.
        • Caranasos T.G.
        • Vavalle J.P.
        Transcatheter versus surgical aortic valve replacement in patients with lower surgical risk scores: a systematic review and meta-analysis of early outcomes.
        Heart Lung Circ. 2017; ([Epub ahead of print])
      1. Dvir D. First Look at Long-term Durability of transcatheter heart valves: assessment of valve function up to 10 years after implantation. Presented at: EuroPCR 2016. May 17, 2016. Paris, France.

        • Joshi V.
        • Prosser K.
        • Richens D.
        Early prosthetic valve degeneration with Mitroflow aortic valves: determination of incidence and risk factors.
        Interact Cardiovasc Thorac Surg. 2014; 19: 36-40
        • Johnston D.R.
        • Soltesz E.G.
        • Vakil N.
        • Rajeswaran J.
        • Roselli E.E.
        • Sabik 3rd, J.F.
        • Smedira N.G.
        • Svensson L.G.
        • Lytle B.W.
        • Blackstone E.H.
        Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants.
        Ann Thorac Surg. 2015; 99: 1239-1247
        • Rodes-Cabau J.
        • Webb J.G.
        • Cheung A.
        • Ye J.
        • Dumont E.
        • Osten M.
        • Feindel C.M.
        • Natarajan M.K.
        • Velianou J.L.
        • Martucci G.
        • DeVarennes B.
        • Chisholm R.
        • Peterson M.
        • Thompson C.R.
        • Wood D.
        • Toggweiler S.
        • Gurvitch R.
        • Lichtenstein S.V.
        • Doyle D.
        • DeLarochelliere R.
        • Teoh K.
        • Chu V.
        • Bainey K.
        • Lachapelle K.
        • Cheema A.
        • Latter D.
        • Dumesnil J.G.
        • Pibarot P.
        • Horlick E.
        Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience.
        J Am Coll Cardiol. 2012; 60: 1864-1875
        • Toggweiler S.
        • Humphries K.H.
        • Lee M.
        • Binder R.K.
        • Moss R.R.
        • Freeman M.
        • Ye J.
        • Cheung A.
        • Wood D.A.
        • Webb J.G.
        5-year outcome after transcatheter aortic valve implantation.
        J Am Coll Cardiol. 2013; 61: 413-419
        • Unbehaun A.
        • Pasic M.
        • Drews T.
        • Penkalla A.
        • Dreysse S.
        • Klein C.
        • Kukucka M.
        • Mladenow A.
        • Hetzer R.
        • Buz S.
        Transapical aortic valve implantation: predictors of survival up to 5 years in 730 patients. An update.
        Eur J Cardiothorac Surg. 2015; 47 (discussion 290): 281-290
        • Bouleti C.
        • Himbert D.
        • Iung B.
        • Alos B.
        • Kerneis C.
        • Ghodbane W.
        • Messika-Zeitoun D.
        • Brochet E.
        • Fassa A.A.
        • Depoix J.P.
        • Ou P.
        • Nataf P.
        • Vahanian A.
        Long-term outcome after transcatheter aortic valve implantation.
        Heart. 2015; 101: 936-942
        • Ludman P.F.
        • Moat N.
        • de Belder M.A.
        • Blackman D.J.
        • Duncan A.
        • Banya W.
        • MacCarthy P.A.
        • Cunningham D.
        • Wendler O.
        • Marlee D.
        • Hildick-Smith D.
        • Young C.P.
        • Kovac J.
        • Uren N.G.
        • Spyt T.
        • Trivedi U.
        • Howell J.
        • Gray H.
        • UK TAVI Steering Committee and the National Institute for Cardiovascular Outcomes Research
        Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012.
        Circulation. 2015; 131: 1181-1190
      2. Douglas PS. Mid-term hemodynamic trends and between echo changes in transcatheter aortic valves in the PARTNER 1 trial: 5-year results. Presented at: TCT 2016. November 1, 2016. Washington, DC.

        • Mack M.J.
        • Leon M.B.
        • Smith C.R.
        • Miller D.C.
        • Moses J.W.
        • Tuzcu E.M.
        • Webb J.G.
        • Douglas P.S.
        • Anderson W.N.
        • Blackstone E.H.
        • Kodali S.K.
        • Makkar R.R.
        • Fontana G.P.
        • Kapadia S.
        • Bavaria J.
        • Hahn R.T.
        • Thourani V.H.
        • Babaliaros V.
        • Pichard A.
        • Herrmann H.C.
        • Brown D.L.
        • Williams M.
        • Akin J.
        • Davidson M.J.
        • Svensson L.G.
        • PARTNER 1 trial investigators
        5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.
        Lancet. 2015; 385: 2477-2484
        • Kapadia S.R.
        • Leon M.B.
        • Makkar R.R.
        • Tuzcu E.M.
        • Svensson L.G.
        • Kodali S.
        • Webb J.G.
        • Mack M.J.
        • Douglas P.S.
        • Thourani V.H.
        • Babaliaros V.C.
        • Herrmann H.C.
        • Szeto W.Y.
        • Pichard A.D.
        • Williams M.R.
        • Fontana G.P.
        • Miller D.C.
        • Anderson W.N.
        • Akin J.J.
        • Davidson M.J.
        • Smith C.R.
        • PARTNER trial investigators
        5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.
        Lancet. 2015; 385: 2485-2491
        • Barbanti M.
        • Petronio A.S.
        • Ettori F.
        • Latib A.
        • Bedogni F.
        • De Marco F.
        • Poli A.
        • Boschetti C.
        • De Carlo M.
        • Fiorina C.
        • Colombo A.
        • Brambilla N.
        • Bruschi G.
        • Martina P.
        • Pandolfi C.
        • Giannini C.
        • Curello S.
        • Sgroi C.
        • Gulino S.
        • Patane M.
        • Ohno Y.
        • Tamburino C.
        • Attizzani G.F.
        • Imme S.
        • Gentili A.
        • Tamburino C.
        5-Year outcomes after transcatheter aortic valve implantation with CoreValve prosthesis.
        JACC Cardiovasc Interv. 2015; 8: 1084-1091
      3. Brecker A, Bleiziffer S, Bozmans J, Gerckens U, Wenaweser P, Tamburino C, Linke A. Four-Year Clinical and Echocardiographic Follow-Up of Aortic Stenosis Patients Implanted with a Self-Expanding Bioprosthesis: The ADVANCE Study. Presented at EuroPCR 2016. Palais des Congrès, Paris, France.

        • Barbanti M.
        • Schiltgen M.
        • Verdoliva S.
        • Bosmans J.
        • Bleiziffer S.
        • Gerckens U.
        • Wenaweser P.
        • Brecker S.
        • Gulino S.
        • Tamburino C.
        • Linke A.
        • ADVANCE Study Investigators
        Three-year outcomes of transcatheter aortic valve implantation in patients with varying levels of surgical risk (from the CoreValve ADVANCE study).
        Am J Cardiol. 2016; 117: 820-827
        • Gilard M.
        • Eltchaninoff H.
        • Donzeau-Gouge P.
        • Chevreul K.
        • Fajadet J.
        • Leprince P.
        • Leguerrier A.
        • Lievre M.
        • Prat A.
        • Teiger E.
        • Lefevre T.
        • Tchetche D.
        • Carrie D.
        • Himbert D.
        • Albat B.
        • Cribier A.
        • Sudre A.
        • Blanchard D.
        • Rioufol G.
        • Collet F.
        • Houel R.
        • Dos Santos P.
        • Meneveau N.
        • Ghostine S.
        • Manigold T.
        • Guyon P.
        • Grisoli D.
        • Le Breton H.
        • Delpine S.
        • Didier R.
        • Favereau X.
        • Souteyrand G.
        • Ohlmann P.
        • Doisy V.
        • Grollier G.
        • Gommeaux A.
        • Claudel J.P.
        • Bourlon F.
        • Bertrand B.
        • Laskar M.
        • Iung B.
        • FRANCE 2 Investigators
        Late outcomes of transcatheter aortic valve replacement in high-risk patients: the FRANCE-2 registry.
        J Am Coll Cardiol. 2016; 68: 1637-1647
        • Abdel-Wahab M.
        • Neumann F.J.
        • Mehilli J.
        • Frerker C.
        • Richardt D.
        • Landt M.
        • Jose J.
        • Toelg R.
        • Kuck K.H.
        • Massberg S.
        • Robinson D.R.
        • El-Mawardy M.
        • Richardt G.
        • CHOICE Investigators
        1-Year outcomes after transcatheter aortic valve replacement with balloon-expandable versus self-expandable valves: results from the CHOICE randomized clinical trial.
        J Am Coll Cardiol. 2015; 66: 791-800
        • Thourani V.H.
        • Ailawadi G.
        • Szeto W.Y.
        • Dewey T.M.
        • Guyton R.A.
        • Mack M.J.
        • Kron I.L.
        • Kilgo P.
        • Bavaria J.E.
        Outcomes of surgical aortic valve replacement in high-risk patients: a multiinstitutional study.
        Ann Thorac Surg. 2011; 91 (discussion 55–56): 49-55
        • Hammermeister K.
        • Sethi G.K.
        • Henderson W.G.
        • Grover F.L.
        • Oprian C.
        • Rahimtoola S.H.
        Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial.
        J Am Coll Cardiol. 2000; 36: 1152-1158
        • Arora S.
        • Ramm C.J.
        • Misenheimer J.A.
        • Vavalle J.P.
        Early transcatheter valve prosthesis degeneration and future ramifications.
        Cardiovasc Diagn Ther. 2017; 7: 1-3
        • Thourani V.H.
        • Kodali S.
        • Makkar R.R.
        • Herrmann H.C.
        • Williams M.
        • Babaliaros V.
        • Smalling R.
        • Lim S.
        • Malaisrie S.C.
        • Kapadia S.
        • Szeto W.Y.
        • Greason K.L.
        • Kereiakes D.
        • Ailawadi G.
        • Whisenant B.K.
        • Devireddy C.
        • Leipsic J.
        • Hahn R.T.
        • Pibarot P.
        • Weissman N.J.
        • Jaber W.A.
        • Cohen D.J.
        • Suri R.
        • Tuzcu E.M.
        • Svensson L.G.
        • Webb J.G.
        • Moses J.W.
        • Mack M.J.
        • Miller D.C.
        • Smith C.R.
        • Alu M.C.
        • Parvataneni R.
        • D'Agostino Jr., R.B.
        • Leon M.B.
        Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis.
        Lancet. 2016; 387: 2218-2225
        • Herrmann H.C.
        • Thourani V.H.
        • Kodali S.K.
        • Makkar R.R.
        • Szeto W.Y.
        • Anwaruddin S.
        • Desai N.
        • Lim S.
        • Malaisrie S.C.
        • Kereiakes D.J.
        • Ramee S.
        • Greason K.L.
        • Kapadia S.
        • Babaliaros V.
        • Hahn R.T.
        • Pibarot P.
        • Weissman N.J.
        • Leipsic J.
        • Whisenant B.K.
        • Webb J.G.
        • Mack M.J.
        • Leon M.B.
        • PARTNER Investigators
        One-year clinical outcomes with SAPIEN 3 transcatheter aortic valve replacement in high-risk and inoperable patients with severe aortic stenosis.
        Circulation. 2016; 134: 130-140
        • Kodali S.
        • Thourani V.H.
        • White J.
        • Malaisrie S.C.
        • Lim S.
        • Greason K.L.
        • Williams M.
        • Guerrero M.
        • Eisenhauer A.C.
        • Kapadia S.
        • Kereiakes D.J.
        • Herrmann H.C.
        • Babaliaros V.
        • Szeto W.Y.
        • Hahn R.T.
        • Pibarot P.
        • Weissman N.J.
        • Leipsic J.
        • Blanke P.
        • Whisenant B.K.
        • Suri R.M.
        • Makkar R.R.
        • Ayele G.M.
        • Svensson L.G.
        • Webb J.G.
        • Mack M.J.
        • Smith C.R.
        • Leon M.B.
        Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis.
        Eur Heart J. 2016; 37: 2252-2262
        • Pomerance A.
        Pathogenesis of aortic stenosis and its relation to age.
        Br Heart J. 1972; 34: 569-574
        • Makkar R.
        • Chakravarty T.
        • Jilaihawi H.
        Transcatheter aortic valve replacement for bicuspid aortic stenosis: are we ready for the challenge?.
        J Am Coll Cardiol. 2016; 68: 1206-1208
        • Yoon S.H.
        • Lefevre T.
        • Ahn J.M.
        • Perlman G.Y.
        • Dvir D.
        • Latib A.
        • Barbanti M.
        • Deuschl F.
        • De Backer O.
        • Blanke P.
        • Modine T.
        • Pache G.
        • Neumann F.J.
        • Ruile P.
        • Arai T.
        • Ohno Y.
        • Kaneko H.
        • Tay E.
        • Schofer N.
        • Holy E.W.
        • Luk N.H.
        • Yong G.
        • Lu Q.
        • Kong W.K.
        • Hon J.
        • Kao H.L.
        • Lee M.
        • Yin W.H.
        • Park D.W.
        • Kang S.J.
        • Lee S.W.
        • Kim Y.H.
        • Lee C.W.
        • Park S.W.
        • Kim H.S.
        • Butter C.
        • Khalique O.K.
        • Schaefer U.
        • Nietlispach F.
        • Kodali S.K.
        • Leon M.B.
        • Ye J.
        • Chevalier B.
        • Leipsic J.
        • Delgado V.
        • Bax J.J.
        • Tamburino C.
        • Colombo A.
        • Sondergaard L.
        • Webb J.G.
        • Park S.J.
        Transcatheter aortic valve replacement with early- and new-generation devices in bicuspid aortic valve stenosis.
        J Am Coll Cardiol. 2016; 68: 1195-1205